Author + information
- Received July 18, 2016
- Revision received December 8, 2016
- Accepted December 16, 2016
- Published online March 13, 2017.
- Frederick A. Masoudi, MD, MSPHa,b,∗ (, )
- Angelo Ponirakis, PhDc,
- James A. de Lemos, MDd,
- James G. Jollis, MDe,
- Mark Kremers, MDf,
- John C. Messenger, MDa,
- John W.M. Moore, MD, MPHg,
- Issam Moussa, MDh,
- William J. Oetgen, MD, MBAc,
- Paul D. Varosy, MDi,
- Robert N. Vincent, MD, CMj,
- Jessica Wei, MD, MSc,
- Jeptha P. Curtis, MDk,
- Matthew T. Roe, MD, MHSl and
- John A. Spertus, MD, MPHm
- aDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado
- bColorado Cardiovascular Outcomes Research Consortium, Denver, Colorado
- cAmerican College of Cardiology Foundation, Washington, DC
- dDepartment of Medicine, University of Texas Southwestern, Dallas, Texas
- eDepartment of Medicine, University of North Carolina, Chapel Hill, North Carolina
- fNovant Health Heart and Vascular Institute, Charlotte, North Carolina
- gDivision of Cardiology, Department of Pediatrics, Rady Children’s Hospital, University of California–San Diego, San Diego, California
- hDivision of Cardiology, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey
- iVA Eastern Colorado Health Care System, University of Colorado, and Colorado Cardiovascular Outcomes Research Group, Denver, Colorado
- jDivision of Cardiology, Department of Pediatrics, Children’s Healthcare of Atlanta, Emory University, Atlanta, Georgia
- kDepartment of Medicine, Yale University, New Haven, Connecticut
- lDuke Cardiovascular Research Institute, Durham, North Carolina
- mDivision of Cardiovascular Diseases, Mid-America Heart Institute, Kansas City, Kansas
- ↵∗Address for correspondence:
Dr. Frederick A. Masoudi, University of Colorado Anschutz Medical Campus, Department of Medicine, 12401 East 17th Avenue, Room 522, Campus Box B132, Aurora, Colorado 80045.
Cardiovascular disease is a leading cause of death and disability in the United States. National programs, such as the National Cardiovascular Data Registry, facilitate assessments of the quality of care and outcomes for broad populations of patients with cardiovascular disease. This report provides data for 2014 from 4 National Cardiovascular Data Registry hospital quality programs: 1) CathPCI (Diagnostic Catheterization and Percutaneous Coronary Intervention) for coronary angiography and percutaneous coronary intervention (667,424 procedures performed in 1,612 hospitals); 2) ICD Registry for implantable cardioverter-defibrillators (158,649 procedures performed in 1,715 hospitals); 3) ACTION–GWTG (Acute Coronary Treatment and Intervention Outcomes Network–Get With The Guidelines) for acute coronary syndromes (182,903 patients admitted to 907 hospitals); and 4) IMPACT (Improving Pediatric and Adult Congenital Treatment) for cardiac catheterization and intervention for pediatric and adult congenital heart disease (20,169 procedures in 76 hospitals). The report provides perspectives on the demographic and clinical characteristics of enrolled patients, characteristics of participating centers, and selected measures of processes and outcomes of care in these programs.
- acute coronary syndromes
- congenital heart disease
- implantable cardioverter-defibrillators
- percutaneous coronary intervention
- quality of care
Dr. Masoudi has a contract with the American College of Cardiology Foundation for his role as Chief Science Officer of the National Cardiovascular Data Registry. Dr. Ponirakis, Dr. Oetgen, and Ms. Wei are employed by the American College of Cardiology Foundation. Dr. de Lemos has received grant support from Roche Diagnostics and Abbott Diagnostics; has served on endpoint committees for Siemen's Health Care and Radiometer; has received consulting income from Roche Diagnostics; and has received honoraria for participation in the data and safety monitoring board or steering committees of Novo Nordisk, St. Jude Medical, and Amgen. Dr. Kremers has equity (<$20,000) in Boston Scientific; provides consulting for Medtronic; and is a member of the Speakers Bureau for Boston Scientific. Dr. Messenger is an investigator in clinical research studies for Philips Medical Systems; and is a member of the Clinical Events Committee of Novate Medical. Dr. Moore is a consultant for pfm Medical; is an investigator in research protocols funded by Medtronic and St. Jude Medical; and is on the medical advisory boards for 480 BioMedical and Transmural Systems. Dr. Curtis receives salary support through a contract with the American College of Cardiology to provide data analytic services and from the Centers for Medicaid & Medicare Services; and has equity in Medtronic. Dr. Roe has received research funding from Eli Lilly, Sanofi, Daiichi-Sankyo, Janssen Pharmaceuticals, Ferring Pharmaceuticals, Myokardia, AstraZeneca, American College of Cardiology, American Heart Association, and the Familial Hypercholesterolemia Foundation; and has received consulting fees or honoraria from PriMed, AstraZeneca, Boehringer Ingelheim, Merck, Actelion, Amgen, Myokardia, Eli Lilly, Novartis, Daiichi-Sankyo, Quest Diagnostics, and Elsevier Publishers. Dr. Spertus is affiliated with the Saint Luke’s Mid America Heart and Institute, which is the major analytic center for the PINNACLE program and receives funding from the American College of Cardiology for this role; is on the Scientific Advisory Board of United Healthcare; provides consulting services for United Healthcare, Novartis, Amgen, and Bayer (all moderate); has copyright to the Kansas City Cardiomyopathy Questionnaire, Seattle Angina Questionnaire, and the Peripheral Artery Questionnaire (significant); has received grants from Gilead, Lilly, Novartis, and Abbott Vascular (all significant); and has equity in Health Outcomes Sciences (significant). All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
- Received July 18, 2016.
- Revision received December 8, 2016.
- Accepted December 16, 2016.
- 2017 American College of Cardiology Foundation